Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 306

1.

Oral anti-pseudomonal antibiotics for cystic fibrosis.

Remmington T, Jahnke N, Harkensee C.

Cochrane Database Syst Rev. 2013 Oct 29;(10):CD005405. doi: 10.1002/14651858.CD005405.pub3. Review. Update in: Cochrane Database Syst Rev. 2016;7:CD005405.

PMID:
24170644
2.

Oral anti-pseudomonal antibiotics for cystic fibrosis.

Remmington T, Jahnke N, Harkensee C.

Cochrane Database Syst Rev. 2016 Jul 14;7:CD005405. doi: 10.1002/14651858.CD005405.pub4. Review.

PMID:
27412131
3.

Oral anti-pseudomonal antibiotics for cystic fibrosis.

Remmington T, Jahnke N, Harkensee C.

Cochrane Database Syst Rev. 2007 Jul 18;(3):CD005405. Review. Update in: Cochrane Database Syst Rev. 2013;10:CD005405.

PMID:
17636796
4.

Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.

Langton Hewer SC, Smyth AR.

Cochrane Database Syst Rev. 2014 Nov 10;(11):CD004197. doi: 10.1002/14651858.CD004197.pub4. Review.

PMID:
25383937
5.

Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.

Langton Hewer SC, Smyth AR.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD004197. doi: 10.1002/14651858.CD004197.pub3. Review. Update in: Cochrane Database Syst Rev. 2014;11:CD004197.

PMID:
19821321
6.

Single versus combination intravenous anti-pseudomonal antibiotic therapy for people with cystic fibrosis.

Elphick HE, Scott A.

Cochrane Database Syst Rev. 2016 Dec 1;12:CD002007. doi: 10.1002/14651858.CD002007.pub4. Review.

PMID:
27907224
7.

Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.

Ryan G, Jahnke N, Remmington T.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD008319. doi: 10.1002/14651858.CD008319.pub2. Review.

PMID:
23235659
8.

Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.

Waters V, Ratjen F.

Cochrane Database Syst Rev. 2015 Mar 5;(3):CD009528. doi: 10.1002/14651858.CD009528.pub3. Review.

PMID:
25741986
9.

Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.

Wood DM, Smyth AR.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD004197. Review. Update in: Cochrane Database Syst Rev. 2009;(4):CD004197.

PMID:
16437476
10.

Nebulised anti-pseudomonal antibiotics for cystic fibrosis.

Ryan G, Mukhopadhyay S, Singh M.

Cochrane Database Syst Rev. 2003;(3):CD001021. Review. Update in: Cochrane Database Syst Rev. 2011;(3):CD001021.

PMID:
12917897
11.

Nebulised anti-pseudomonal antibiotics for cystic fibrosis.

Ryan G, Mukhopadhyay S, Singh M.

Cochrane Database Syst Rev. 2000;(2):CD001021. Review. Update in: Cochrane Database Syst Rev. 2003;(3):CD001021.

PMID:
10796732
12.

Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis.

Waters V, Ratjen F.

Cochrane Database Syst Rev. 2015 Nov 2;(11):CD006961. doi: 10.1002/14651858.CD006961.pub3. Review.

PMID:
26522473
13.

Prophylactic anti-staphylococcal antibiotics for cystic fibrosis.

Smyth AR, Walters S.

Cochrane Database Syst Rev. 2014 Nov 24;(11):CD001912. doi: 10.1002/14651858.CD001912.pub3. Review.

PMID:
25419599
14.

Macrolide antibiotics for cystic fibrosis.

Southern KW, Barker PM, Solis-Moya A, Patel L.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD002203. doi: 10.1002/14651858.CD002203.pub4. Review.

PMID:
23152214
15.

Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.

Waters V, Ratjen F.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD009528. doi: 10.1002/14651858.CD009528.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;3:CD009528.

PMID:
23152277
16.

Macrolide antibiotics for cystic fibrosis.

Southern KW, Barker PM, Solis-Moya A, Patel L.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD002203. doi: 10.1002/14651858.CD002203.pub3. Review. Update in: Cochrane Database Syst Rev. 2012;11:CD002203.

PMID:
22161368
17.

Antibiotics for preventing lower respiratory tract infections in high-risk children aged 12 years and under.

Onakpoya IJ, Hayward G, Heneghan CJ.

Cochrane Database Syst Rev. 2015 Sep 26;(9):CD011530. doi: 10.1002/14651858.CD011530.pub2. Review.

PMID:
26408070
18.

Elective versus symptomatic intravenous antibiotic therapy for cystic fibrosis.

Breen L, Aswani N.

Cochrane Database Syst Rev. 2012 Jul 11;(7):CD002767. doi: 10.1002/14651858.CD002767.pub2. Review.

PMID:
22786481
19.

Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis.

Waters V, Ratjen F.

Cochrane Database Syst Rev. 2008 Jul 16;(3):CD006961. doi: 10.1002/14651858.CD006961.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;11:CD006961.

PMID:
18646176
20.

Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.

Jain K, Wainwright C, Smyth AR.

Cochrane Database Syst Rev. 2016 Jan 21;(1):CD009530. doi: 10.1002/14651858.CD009530.pub3. Review.

PMID:
26797965

Supplemental Content

Support Center